TURNING POINT THERAPEUTICS I's ticker is TPTX and the CUSIP is 90041T108. A total of 156 filers reported holding TURNING POINT THERAPEUTICS I in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $7,000 | -97.0% | 97 | -98.9% | 0.00% | – |
| Q1 2022 | $230,000 | -36.8% | 8,546 | +11.6% | 0.00% | – |
| Q4 2021 | $364,000 | -28.8% | 7,658 | -0.4% | 0.00% | – |
| Q3 2021 | $511,000 | -14.0% | 7,686 | +1.1% | 0.00% | -100.0% |
| Q2 2021 | $594,000 | +22.7% | 7,602 | +48.5% | 0.00% | – |
| Q1 2021 | $484,000 | -14.8% | 5,120 | +9.9% | 0.00% | -100.0% |
| Q4 2020 | $568,000 | +61.4% | 4,660 | +15.3% | 0.00% | – |
| Q3 2020 | $352,000 | +70.9% | 4,040 | +27.0% | 0.00% | – |
| Q2 2020 | $206,000 | +80.7% | 3,180 | +25.2% | 0.00% | – |
| Q1 2020 | $114,000 | – | 2,540 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MPM BioImpact LLC | 308,686 | $13,786,000 | 8.42% |
| Cormorant Asset Management, LP | 3,056,797 | $136,517,000 | 6.34% |
| venBio Partners LLC | 160,333 | $7,160,000 | 6.10% |
| Burrage Capital Management LLC | 77,172 | $3,250,000 | 3.20% |
| Orbimed Advisors | 2,745,327 | $122,606,000 | 2.06% |
| Parkman Healthcare Partners LLC | 80,318 | $3,587,000 | 1.66% |
| SECTORAL ASSET MANAGEMENT INC | 117,800 | $5,261,000 | 1.01% |
| DAFNA Capital Management LLC | 46,908 | $2,095,000 | 0.87% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 35,000 | $1,542,000 | 0.70% |
| Nicholas Investment Partners, LP | 75,487 | $3,371,000 | 0.66% |